financetom
Business
financetom
/
Business
/
Ucore Rare Metals Upsizes Brokered LIFE Offering for Up to $14 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ucore Rare Metals Upsizes Brokered LIFE Offering for Up to $14 Million
Jun 9, 2025 6:08 AM

08:47 AM EDT, 06/09/2025 (MT Newswires) -- Ucore Rare Metals ( UURAF ) , which gained near 15% on Friday, increased the size of its previously announced "best efforts" private placement to up to $14 million from up to $10 million.

On Monday, the company said the offering is comprised of the sale of up to 11.7 million units at $1.20 apiece. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant.

As previously disclosed, net proceeds are expected to be used for the finalization of upstream mixed-rare-earth feedstock agreements and downstream customer offtake agreements for its planned strategic metals complex in Louisiana, USA; the completion of its existing obligations pursuant to its agreements with the U.S. Department of Defense and Natural Resources Canada; and commercial scale column confirmation testing. It also intends to use proceeds for progressing engineering drawings and plans, which are currently ongoing, for its planned SMC and for general working capital needs.

Closing of the offering is expected on or about June 19 and is subject to certain closing conditions.

Shares of the company closed down $0.17 to $1.32 on Friday on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate
PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate
Dec 2, 2024
10:41 AM EST, 12/02/2024 (MT Newswires) -- PTC Therapeutics ( PTCT ) signed a licensing deal with Novartis ( NVS ) unit Novartis Pharmaceuticals worth up to $2.9 billion for PTC518, its candidate treatment for Huntington's disease, the companies said in separate Monday statements. The Swiss pharmaceutical giant will pay PTC $1 billion upfront under the terms of the license...
AMC Entertainment Stock Is Rising Monday: What's Going On?
AMC Entertainment Stock Is Rising Monday: What's Going On?
Dec 2, 2024
AMC Entertainment Holdings Inc ( AMC ) shares are trading higher. The company on Monday announced attendance records for the Thanksgiving holiday period. What Happened: AMC on Monday said the five-day Thanksgiving holiday period was the biggest and busiest in AMC history by attendance, admissions, revenue and food and beverage. “This 5-day Thanksgiving period in 2024 was one for the...
Xcel Energy Launches Cash Tender Offers to Buy Up to $110 Million in First Mortgage Bonds
Xcel Energy Launches Cash Tender Offers to Buy Up to $110 Million in First Mortgage Bonds
Dec 2, 2024
10:38 AM EST, 12/02/2024 (MT Newswires) -- Xcel Energy ( XEL ) said Monday it has launched cash tender offers to buy up to $110 million of outstanding first mortgage bonds issued by its subsidiary Northern States Power. The cash tender offers include $700 million of 2.60% first mortgage bonds, series due June 1, 2051; $600 million of 2.90% first...
RedHill Biopharma Awarded $8 Million in Legal Case Against Kukbo
RedHill Biopharma Awarded $8 Million in Legal Case Against Kukbo
Dec 2, 2024
10:37 AM EST, 12/02/2024 (MT Newswires) -- RedHill Biopharma ( RDHL ) said Monday it has been awarded approximately $8 million, including nearly $1.5 million in interest, by the New York Supreme Court in a legal case against Kukbo. The court ruled that Kukbo failed to make payments to RedHill Biopharma ( RDHL ) according to their agreements on Oct....
Copyright 2023-2026 - www.financetom.com All Rights Reserved